Activity Goals

Case 1: MDS

Evaluation for Transplant

CCI Impacts Survival

Patient Characteristics -- MDS

HSCT for AML and MDS By Age: TRM and Relapse

Overall Survival: HSCT for MDS By Age

Conditioning Regimens

Pharmacokinetics: Goal of Therapy

Implications of Altered Drug Distribution of Bu

Improving Outcomes

Response to Azacitidine: IWG Criteria ITT Cohort (n = 282)

New Cytogenetic Scoring System in MDS

Survival by 5-group Cytogenetic Classification

Azacitidine After Allo-SCT

3-Year OS Based On Pretransplantation Treatment

Case 2: Myeloma Transformed into AML

Life Expectancy at Age 65 Years and 85 Years by Gender

Impact of Charlson Comorbidity Index

2-year NRM Stratified by HCTCI Scores

Chronic GVHD

Functional Assessment

Case 2 (cont)

Case 3: CML

Case 3: CML (cont)

Multivariate Analysis: DFS

Conditioning Regimens

Mutation-Dependent Maintenance Therapy

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)